How do you assess the track record of a strategy?

How do you assess the track record of a strategy?

25-02-2015 | Insight

How do you assess the track record of a strategy in order to ensure the best possible future returns? The solution to this problem was discovered by former Guinness employee, William Sealy Gosset. He needed a cheap way to test the quality of barley for brewing beer and devised the t-value to tackle the problem of drawing conclusions based on a small sample size using a formula known as the t-statistic.

The formula can be applied to many industries, including finance, because investors often face a similar problem of not having an unlimited sample size. The t-value can be used to test the statistical significance of excess returns - the returns of a strategy relative to an index. The standard deviation of these returns is the tracking error (TE). Once the t-value is calculated, it can be compared to the t-statistic for T-1 degrees of freedom and a 95% significance level. The outcome of this can be determined by the standard t-tables.
If you apply this formula to Robeco Core Developed Markets* (Institutional Global Enhanced Index fund), which has an average annual outperformance since inception relative to the MSCI World of 1.17%, a TE of 1.09%, and IR of 1.08 and a >10-year track record, the t-value is 1.09*√10.1= 3.46. This is statistically significant; because the critical t-statistic for 95% significance is 1.86.

* The value of your investments may fluctuate. Past results are no guarantee of future performance.

Stay informed on Quant investing with monthly mail updates
Stay informed on Quant investing with monthly mail updates
Subjects related to this article are:

Disclaimer Robeco Switzerland Ltd.

The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients. 

The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA). 

Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile. 

Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports. 

By clicking “I agree” you confirm that you/the company you represent falls under one of the above-mentioned categories of addressees and that you have read, understood and accept the terms of use for this website.

I Disagree